Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 15Breast Neoplasms 11Neoplasms 8Fatigue 8Cognitive Dysfunction 3Lung Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Postoperative Bowel Functions 1Polycystic Ovary Syndrome 1Parasomnias 1Obesity 1Multiple Endocrine Neoplasia Type 1 1Metabolic Syndrome 1Lymphoma, Follicular 1Liver Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1Asthenia 1Arthritis 1Arthralgia 1Adenomatous Polyps 1

Interventions

Sorafenib 68Bevacizumab 44Oxaliplatin 25Doxorubicin 22Gemcitabine 21Fluorouracil 21Radiosurgery 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17lenvatinib 17Cisplatin 17Capecitabine 17atezolizumab 14Leucovorin 14Hepatectomy 14Radiotherapy 12tremelimumab 10Irinotecan 10Drug Therapy 10Cyclophosphamide 10Carboplatin 10Blood Specimen Collection 10Ipilimumab 9regorafenib 8Liver Transplantation 8Everolimus 8Cryosurgery 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Walking × Clear all
NCT01542281 2012-03-02

Pre-habilitation to Improve Outcomes in Patients Undergoing Liver Resection for Cancer

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Unknown
64 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡